Access Biologicals is actively collecting serum and plasma from patients being vaccinated for COVID-19 COVID-19 J&J, Moderna and Pfizer Vaccine Panels Longitudinal Vaccine Panel (Moderna) 6 samples per subject Following vaccinated donors pre-vaccine to 6 months...
Abstract Seroconversion panels are an important tool for investigating antibody responses in acute and chronic phases of disease and development of serological assays for viral diseases including COVID-19. Globally it is anticipated that vaccines against SARS-CoV-2...
Did you know Access Biologicals offers panels for assay development, validation and qualification?! For more information about our products, please visit: Panels, COVID-19 Panels & Seroconversion Panels ANA (Antinuclear Antibody) Anti-CCP ((cyclic...
In collaboration, Grifols and Access Biologicals have published “Available COVID-19 serial seroconversion panel for validation of SARS-CoV-2 antibody assays.” Abstract Seroconversion panels are an important tool for investigating antibody responses and...
Access Biologicals is now collecting samples from donors being vaccinated for COVID-19. 15 Subject Panel 3 samples per subject Sample 1: ≤ 2 days prior to the first vaccination Sample 2: ≤ 2 days prior to their second vaccination Sample 3: 13-15 days post their second...
Access Biologicals is now offering Hepatitis A (HAV) Seroconversion Panels (Catalogue No: HAV001SCP) intended for use by diagnostic manufacturers and researchers during assay development, evaluation as well as troubleshooting HAV test methods. The HAV Seroconversion...
Recent Comments